Experienced in Disseminated Tuberculosis

Alena M. Skrahina

MI, BY 
Experienced in Disseminated Tuberculosis
MI, BY 
OverviewLocationsClinical Research

Overview

Alena Skrahina practices in Belarus. Ms. Skrahina is rated as an Experienced expert by MediFind in the treatment of Disseminated Tuberculosis. Her top areas of expertise are Pulmonary Tuberculosis, HIV/AIDS, Disseminated Tuberculosis, and Magnesium Deficiency.

Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Disseminated Tuberculosis.

Gender
Female

Locations

MI, Belarus
Other Locations
Minsk, HM, Belarus

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised, Controlled, Open-Label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients With Pulmonary Multidrug Resistant Tuberculosis
A Randomised, Controlled, Open-Label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients With Pulmonary Multidrug Resistant Tuberculosis
Enrollment Status: Completed
Publish Date: May 01, 2024
Intervention Type: Drug
Study Drugs: Bedaquiline, Pretomanid, Moxifloxacin, Linezolid, Clofazimine, Standard of care
Study Phase: Phase 2/Phase 3
endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB With Regimens Containing Bedaquiline or Delamanid
endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB With Regimens Containing Bedaquiline or Delamanid
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Other
View 1 Less Clinical Trial

109 Total Publications

Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.
Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Skrahina's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile